WHO Model Prescribing Information: Drugs Used in Anaesthesia
(1989; 60 pages) [French] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuPremedication
Fermer ce répertoireGeneral anaesthetics and oxygen
Afficher le documentKetamine
Afficher le documentThiopental
Afficher le documentEther
Afficher le documentHalothane
Afficher le documentTrichloroethylene
Afficher le documentNitrous oxide
Afficher le documentOxygen
Ouvrir ce répertoire et afficher son contenuLocal anaesthetics
Ouvrir ce répertoire et afficher son contenuNon-opioid analgesics
Ouvrir ce répertoire et afficher son contenuOpioid analgesics and antagonists
Ouvrir ce répertoire et afficher son contenuMuscle relaxants and cholinesterase inhibitors
Ouvrir ce répertoire et afficher son contenuBlood substitutes
Ouvrir ce répertoire et afficher son contenuSolutions for correcting water and electrolyte imbalance
Ouvrir ce répertoire et afficher son contenuAntacid for use in obstetric practice
Afficher le documentAnaesthesia at the District Hospital
Afficher le documentSelected WHO publications of related interest
Afficher le documentBack cover
 

Nitrous oxide

Group: inhalational anaesthetic gas

General information

Nitrous oxide is a colourless gas with a slightly sweetish odour. It is neither flammable nor explosive. It is a cerebral depressant and produces light anaesthesia without demonstrably depressing the respiratory or vasomotor centre provided that normal oxygen tension is maintained.

Advantages

Nitrous oxide reduces the requirement for other more potent and intrinsically more toxic anaesthetic agents. It has a strong analgesic action. Induction is rapid and not unpleasant although transient excitement may occur. Recovery time rarely exceeds 1-4 minutes even after prolonged administration.

Disadvantages

Nitrous oxide is expensive to buy and to transport. It must be used in conjunction with more potent anaesthetics and muscle relaxants to produce a state of full surgical anaesthesia.

Clinical information

Uses

• Maintenance of surgical anaesthesia in combination with other anaesthetic agents (halothane, ether, thiopental or ketamine) and muscle relaxants.

• In subanaesthetic doses, to provide analgesia for obstetric practice, for emergency management of injuries, during postoperative physiotherapy and for refractory pain in terminal illness.

Dosage and administration

For the maintenance of anaesthesia, nitrous oxide must always be mixed with at least 30% oxygen. This is usually accomplished using a compressed-gas anaesthetic machine.

For analgesia, a concentration of 50% nitrous oxide with 50% oxygen usually suffices.

Contraindications

Any closed gas-filled space tends to expand during administration of nitrous oxide. It is therefore contraindicated in patients with demonstrable collections of air in the pleural, pericardial or peritoneal space; intestinal obstruction; occlusion of the middle ear; arterial air embolism; decompression sickness; chronic obstructive airway disease; or emphysema. It is also contraindicated in patients who have recently undergone pneumoencephalography.

Precautions

Continued administration of oxygen may be necessary during recovery especially in elderly patients.

Adverse effects

The incidence of nausea and vomiting increases with the duration of anaesthesia. Because prolonged and repeated exposure may be associated with bone-marrow depression and a teratogenic risk, precautions should be taken to minimize ambient concentrations in operating theatres.

Drug interactions

Addition of 50% nitrous oxide/oxygen mixture to an inhalational anaesthetic reduces the required dosage of the latter by about 50%.

Storage

Nitrous oxide is supplied under pressure in cylinders, which must be kept below 25°C. It must be obtained from a reliable source since contamination with higher oxides of nitrogen, including nitric oxide and nitrogen peroxide, has caused deaths.

Cylinders containing premixed oxygen 50% and nitrous oxide 50% are available for analgesia in some countries. However, the constituents separate out at -6°C, in which case adequate mixing must be assured before use. When the two components are supplied from separate cylinders a safety device must be installed that interrupts the How of nitrous oxide should the oxygen pressure fall.

Identification of cylinders

An ISO standard1 requires that cylinders containing nitrous oxide should bear the name of the contents in legible and permanent characters and, preferably, also the chemical symbol N2O. The neck, from the valve to the shoulder, should be coloured blue. Cylinders containing nitrous oxide and oxygen mixtures should be similarly labelled, and the neck coloured white and blue.

1International Standard 32. Gas cylinders for medical use - marking for identification of content. Switzerland, International Organization for Standardization, 1977.

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018